Ludwig Enterprises (Ludwig Enterprises) Pre-Tax Income : $-2.51 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Ludwig Enterprises Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Ludwig Enterprises's pretax income for the three months ended in Mar. 2024 was $-1.61 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.51 Mil. Ludwig Enterprises's pretax margin was -12,392.31%.

Ludwig Enterprises Pre-Tax Income Historical Data

The historical data trend for Ludwig Enterprises's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ludwig Enterprises Pre-Tax Income Chart

Ludwig Enterprises Annual Data

Trend

Dec22

Dec23

Pre-Tax Income

-0.97

-2.46

Ludwig Enterprises Quarterly Data
	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial			-0.43	-0.98	-0.45	-0.45	-1.61

Competitive Comparison of Ludwig Enterprises's Pre-Tax Income

For the Medical Devices subindustry, Ludwig Enterprises's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ludwig Enterprises's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ludwig Enterprises's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ludwig Enterprises's Pre-Tax Income falls into.

Ludwig Enterprises Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ludwig Enterprises's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.454	+	-0.517	+	-0.485	+	0	+	-0.00099999999999989
	=	-2.46

Ludwig Enterprises's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.398	+	-0.52	+	-0.016	+	0	+	-0.677
	=	-1.61

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.51 Mil.

Ludwig Enterprises (OTCPK:LUDG) Pre-Tax Income Explanation

Ludwig Enterprises's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.611	/	0.013
	=	-12,392.31%

Ludwig Enterprises Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ludwig Enterprises's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Ludwig Enterprises (Ludwig Enterprises) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ludwig Enterprises Inc (OTCPK:LUDG) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1749 VICTORIAN AVENUE, Suite C-350, Sparks, NV, USA, 89431

Website

https://www.ludwigent.com

Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.